e-learning
resources
Munich 2014
Monday, 08.09.2014
Tuberculosis: from epidemiology to therapy 3
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis
M. Ponnana, R. Sivangala, L. Joshi, S. Thada, V. L. Valluri, S. L. Gaddam (Hyderabad, India)
Source:
International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Session:
Tuberculosis: from epidemiology to therapy 3
Session type:
Thematic Poster Session
Number:
2685
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ponnana, R. Sivangala, L. Joshi, S. Thada, V. L. Valluri, S. L. Gaddam (Hyderabad, India). Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2685
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Vitamin D levels in patients with a clinical diagnosis of tuberculosis
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013
Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Impact of diabetes on the presenting features of tuberculosis patients
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Screening of diabetes mellitus among new cases of tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013
Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
A study of immunogenetic markers associated With tuberculosis and diabetes mellitus
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Vitamin D supplementation in health and latent tuberculosis promotes regulatory T cell expression
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept